Stocks
VivoPower PLC

VivoPower PLCVIVO

NASDAQHealthcareDiagnostics & Research$3.99+0.00%

Price as of · delayed, not real-time

Specializing in diagnostic testing solutions, this company develops and manufactures tests for infectious diseases, gastrointestinal infections, and lead poisoning. Investors monitor its performance due to its niche position in life science tools and recurring revenue from clinical labs.

Market Cap: $1.5B52W Range: $1.20-$6.86

Congressional Interest in VivoPower PLC (VIVO)

3 members of Congress have disclosed 8 trades in VivoPower PLC (VIVO), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 6 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.

Total Disclosures
8
Unique Politicians
3
Buys
2
Sells
6

Who in Congress Is Trading VIVO?

2021-02-23$1K-$15K
Stock
2020-11-13$1K-$15K
Stock
2020-09-16$1K-$15K
Stock
2020-09-15$1K-$15K
Stock
2020-08-31$1K-$15K
Stock
2015-02-19$15K-$50K
Stock
2008-12-02
Stock
2008-12-02
Stock